for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Market News

BRIEF-Hls Therapeutics Announces Qtrly Net Loss $0.19 Per Common Share

May 16 (Reuters) - HLS Therapeutics Inc:

* HLS THERAPEUTICS ANNOUNCES Q1 2018 FINANCIAL RESULTS

* CASH AND CASH EQUIVALENTS $53.8 MILLION AT END OF Q1

* Q1 REVENUE $13.2 MILLION VERSUS $15.6 MILLION

* QTRLY NET LOSS $0.19 PER COMMON SHARE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up